Merck’s Julie Gerberding, a ‘vaccine optimist,’ on Covid-19 and what comes next
Julie Gerberding, the chief patient officer at Merck, joined STAT’s Helen Branswell for a wide-ranging discussion of efforts.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario